Trexquant Investment’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Sell |
36,018
-67,965
| -65% | -$3.76M | 0.02% | 884 |
|
|
2025
Q1 | $5.03M | Buy |
103,983
+11,195
| +12% | +$541K | 0.06% | 501 |
|
|
2024
Q4 | $3.58M | Buy |
92,788
+69,697
| +302% | +$2.69M | 0.04% | 645 |
|
|
2024
Q3 | $1.04M | Sell |
23,091
-57,523
| -71% | -$2.59M | 0.01% | 1039 |
|
|
2024
Q2 | $2.79M | Sell |
80,614
-21,765
| -21% | -$754K | 0.04% | 610 |
|
|
2024
Q1 | $2.96M | Buy |
+102,379
| New | +$2.96M | 0.06% | 501 |
|
|
2023
Q3 | – | Sell |
-11,413
| Closed | -$315K | – | 1742 |
|
|
2023
Q2 | $315K | Buy |
+11,413
| New | +$315K | 0.01% | 1178 |
|
|
2022
Q4 | – | Sell |
-22,421
| Closed | -$189K | – | 1662 |
|
|
2022
Q3 | $189K | Buy |
+22,421
| New | +$189K | 0.01% | 1205 |
|
|
2022
Q2 | – | Sell |
-9,795
| Closed | -$232K | – | 1799 |
|
|
2022
Q1 | $232K | Buy |
+9,795
| New | +$232K | 0.01% | 1135 |
|
|
2021
Q2 | – | Sell |
-10,522
| Closed | -$273K | – | 1421 |
|
|
2021
Q1 | $273K | Sell |
10,522
-7,552
| -42% | -$196K | 0.03% | 805 |
|
|
2020
Q4 | $364K | Buy |
+18,074
| New | +$364K | 0.04% | 583 |
|
|
2020
Q3 | – | Sell |
-10,707
| Closed | -$189K | – | 1477 |
|
|
2020
Q2 | $189K | Sell |
10,707
-9,774
| -48% | -$173K | 0.01% | 1058 |
|
|
2020
Q1 | $145K | Buy |
+20,481
| New | +$145K | 0.01% | 1013 |
|
|
2019
Q1 | – | Sell |
-18,317
| Closed | -$123K | – | 1246 |
|
|
2018
Q4 | $123K | Sell |
18,317
-11,263
| -38% | -$75.6K | 0.01% | 978 |
|
|
2018
Q3 | $304K | Buy |
+29,580
| New | +$304K | 0.02% | 684 |
|
|
2018
Q2 | – | Sell |
-22,506
| Closed | -$193K | – | 1141 |
|
|
2018
Q1 | $193K | Buy |
22,506
+5,400
| +32% | +$46.3K | 0.01% | 957 |
|
|
2017
Q4 | $356K | Buy |
+17,106
| New | +$356K | 0.04% | 664 |
|